Clinical Trial Update: AT1019 Plus SBRT and PD-1 Inhibitor for Advanced Solid Tumors: An IIT Study [Phase 1]

View source ↗

Summary

An Investigator Initiated Trial Phase 1 study is evaluating AT1019 in combination with SBRT and a PD-1 inhibitor for patients with advanced solid tumors, curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• AT1019 (AT-1019)
• PD-1 inhibitor

Snippet

Sponsor: The Affiliated Hospital of Xuzhou Medical University | Conditions: Advanced Solid Tumors | Phase 1 | Status: RECRUITING